Chapman University School of Pharmacy (CUSP), in collaboration with Amgen Inc., is recruiting one post-graduate Chapman-Amgen Oncology Medical Affairs Fellow to start in July 2020.
The outcome goals of this 2-year fellowship will prepare graduate to:
Actively participate in specific areas of medical affairs through intensive, hands-on training in the settings of academia, clinical practices, and industry to gain expertise in medical affairs
Promote the role and value of a clinically-trained pharmacist in medical affairs within the pharmaceutical industry
Become a highly competent candidate to be recruited by the pharmaceutical industry
The fellow will spend the first 6 months focusing on clinical and inter-professional experience training at CUSP located in Irvine, California, followed by 18 months at Amgen Inc. located at Thousand Oaks, California. A new fellow will be recruited every academic year.
Academic: The applicant must have a Doctor of Pharmacy degree from an accredited school or college of pharmacy and should obtain a California Pharmacist license by October 1st after starting the fellowship.
Professional Experience: PGY1 or equivalent is preferred.
Interview: An invited onsite interview with presentation is required. Application will be accepted beginning Oct. 1, 2019.
Letter of Intent (initial application)
Curriculum Vitae (CV) (initial application)
Unofficial Transcripts (Applicant may provide copies of their official transcripts)
Three Letters of Recommendation with at least two from pharmacy professionals
Please submit initial application with Letter of Intent and Curriculum Vitae to firstname.lastname@example.org and request an interview through PPS.
For specific questions and further information, please contact the program team members listed below.
Additional Salary Information: Annual Salary: $50,000 plus benefits;
Annual Travel Reimbursement: $1500;
Vacation: 2 weeks per year;
Relocation Reimbursement, if qualified.
About Chapman University School of Pharmacy
Located on the Harry and Diane Rinker Health Science Campus in Irvine, California, the Chapman University School of Pharmacy (CUSP) engages student pharmacists in science-based, personalized, interdisciplinary education and training.
As Orange County’s first school of pharmacy, CUSP’s three-year, accelerated curricular program is designed and developed to provide our pharmacy graduate with the knowledge and practice-ready skills that are essential to provide patient-centered care, manage medication use systems, promote health and wellness, and be advocates of population-based care. Our goal is to create a model patient safety curriculum, including co-curriculum and interprofessional education.
Our vision for CUSP is to enhance global health delivery and the biopharmaceutical and biomedical sciences. We are molding pharmacy practitioners and scientists who possess a deep scientific foundation, a passion for human health improvement and the caring concern needed to make a difference in people's lives.
CUSP provides students with a personalized, interdisciplinary approach to education and research that combines a comprehensive education in the foundations of pharmaceutical scienc...es, ethics, and regulatory issues related to research trials from bench work to translational science with experience in leadership, innovation, and entrepreneurship.
For more information, visit www.chapman.edu/pharmacy and follow us on www.twitter.com/ChapmanPharmacy.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.